Literature DB >> 3046354

Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy.

J Rubin1, V L Yu.   

Abstract

Malignant external otitis is an infection of the external ear canal, mastoid, and base of the skull caused by Pseudomonas aeruginosa. The condition occurs primarily in elderly patients with diabetes mellitus. Current theories on pathogenesis and anatomic correlations are reviewed. Severe, unrelenting otalgia and persistent otorrhea are the symptomatic hallmarks of the disease, whereas an elevated erythrocyte sedimentation rate is the only distinctive laboratory abnormality. Iatrogenic causes such as administration of broad-spectrum antibiotics and aural irrigation may play a predisposing role in high-risk populations. The disease can result in cranial polyneuropathies (with facial nerve [VII] paralysis being the most common) and death. The mainstay of treatment is administration of antipseudomonal antibiotics for four to eight weeks. Recurrence is common, and mortality remains at about 20 percent despite antibiotic therapy. Given the increasing longevity of diabetic patients, the frequency of this disease is increasing. Internists, family practitioners, and ambulatory care physicians must now be cognizant of the presenting symptoms, while infectious disease specialists and otolaryngologists need to be appraised of strides in diagnosis and therapy. The role of surgery should be minimized. Use of new diagnostic radiologic modalities and new antipseudomonal antibiotics discussed in this review should lead to improved outcome.

Entities:  

Mesh:

Year:  1988        PMID: 3046354     DOI: 10.1016/0002-9343(88)90592-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  32 in total

Review 1.  Treatment of otitis externa in children.

Authors:  I Brook
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

2.  Diffusion MR imaging features of skull base osteomyelitis compared with skull base malignancy.

Authors:  B Ozgen; K K Oguz; A Cila
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-14       Impact factor: 3.825

3.  Extensive Skull Base Osteomyelitis Secondary to Malignant Otitis Externa.

Authors:  Luca Bruschini; Stefano Berrettini; Cambi Christina; Simone Ferranti; Silvia Fabiani; Marina Cavezza; Francesca Forli; Amelia Santoro; Enrico Tagliaferri
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

4.  Malignant otitis external-our experience.

Authors:  R B Sardesai; T Krishnakumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2002-04

5.  The Role of Quinolones in Upper Respiratory Tract Infections.

Authors:  Ronald F. Grossman
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

Review 6.  Necrotizing otitis externa: 19 cases' report.

Authors:  Ines Hariga; Ali Mardassi; Faten Belhaj Younes; Mohamed Ben Amor; Sarra Zribi; Olfa Ben Gamra; Chiraz Mbarek; Abdelkader El Khedim
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01-08       Impact factor: 2.503

Review 7.  Diseases and drug-related interventions affecting host defence.

Authors:  S de Marie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

8.  Usefulness of CT scans in malignant external otitis: effective tool for the diagnosis, but of limited value in predicting outcome.

Authors:  Holger Sudhoff; Sandeep Rajagopal; Navin Mani; Ioannis Moumoulidis; Patrick R Axon; David Moffat
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-08-07       Impact factor: 2.503

Review 9.  The use of oral fluoroquinolones in nursing home patients.

Authors:  T M File; J S Tan
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

10.  The significance of tissue biopsy for fungi in necrotizing otitis externa.

Authors:  Rani Abu Eta; Haim Gavriel; Kleid Stephen; Ephraim Eviatar; Eyal Yeheskeli
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-05       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.